Weitzel and Blazer win ASHG Arno Motulsky-Barton Childs Award

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Jeffrey N.Weitzel
Kathleen Blazer

City of Hope’s Jeffrey N. Weitzel and Kathleen Blazer are the 2019 recipients of the American Society of Human Genetics’ Arno Motulsky-Barton Childs Award for Excellence in Human Genetics Education.

Weitzel is Chief of the Division of Clinical Cancer Genomics and the Cancer Screening and Prevention Program at City of Hope. Blazer directs City of Hope’s Cancer Genomics Education Program.

This award recognizes individuals for contributions of exceptional quality and importance to human genetics education internationally. Awardees have had long-standing involvement in genetics education, producing diverse contributions of substantive influence on individuals and/or organizations.

Weitzel and Blazer will receive the award, including a plaque and monetary prize, during ASHG’s 69th Annual Meeting Oct. 15 in Houston.

Weitzel and Blazer have worked together for more than 20 years to provide innovative and impactful cancer genomics education to clinicians and researchers from diverse training backgrounds and practice settings across the United States and internationally. Their NCI-funded CGEP initiatives have ranged from educating primary care physicians for referral-level competence, to preparing master’s and doctoral clinicians for leadership in translational cancer genomics research.

Table of Contents

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login